According to the current research content, the targets of ferroptosis in lung cancer mainly focus on the regulation of antioxidant pathways, among which GPX4 and SLC7A11 are the core targets of the GSH-dependent antioxidant pathway. This evidence concerns the gene GPX4 and lung carcinoma.